Skip to main content

Table 3 Comparison of the incidence of MAE, new-onset MI, stroke, and all-cause death among the groups after propensity score matching

From: Comparison of the effects of triglyceride variability and exposure estimate on clinical prognosis in diabetic patients

 

Low CV (n = 4558)

High CV (n = 4558)

p

Low CEE (n = 3330)

High CEE (n = 3330)

p

MAE

349 (7.7)

414 (9.1)

0.01

304 (9.1)

286 (8.6)

0.44

New-onset MI

73 (1.6)

83 (1.8)

0.42

63 (1.9)

64 (1.9)

0.93

New-onset stroke

213 (4.7)

221 (4.9)

0.69

181 (5.4)

172 (5.2)

0.62

All-cause death

95 (2.1)

132 (2.9)

0.01

89 (2.7)

70 (2.1)

0.13

  1. p is the value of the log-rank test
  2. Values are presented as number of incidence (%)
  3. MAE major adverse event, MI myocardial infarction